DT56a (Tofupill®/Femarelle™) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus

Journal of Steroid Biochemistry and Molecular Biology

Volumn 86, Issue 1, 2003, Pages 93-98

  Somjen, Dalia ^a   Yoles, Israel ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bone; Cartilage; Creatine kinase; DT56a; Estradiol; Phytoestrogens; Raloxifene; Uterus

Indexed keywords

CREATINE KINASE BB; ESTRADIOL; PHYTOESTROGEN; PLANT EXTRACT; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TOFUPILL; CREATINE KINASE; DT56A; ESTROGEN; ISOENZYME; ISOFLAVONE DERIVATIVE; PLANT MEDICINAL PRODUCT;

ANIMAL TISSUE; ARTICLE; BONE TISSUE; CARTILAGE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; ESTROGEN ACTIVITY; FEMALE; NONHUMAN; OVARIECTOMY; RAT; SKELETAL MUSCLE; SOYBEAN; UTERUS; ANIMAL; BONE; CHEMISTRY; COMPARATIVE STUDY; DIAPHYSIS; ENZYMOLOGY; METABOLISM; WISTAR RAT;

GLYCINE MAX;

ANIMALS; BONE AND BONES; CARTILAGE; CREATINE KINASE; DIAPHYSES; ESTRADIOL; ESTROGENS, NON-STEROIDAL; FEMALE; ISOENZYMES; ISOFLAVONES; PHYTOESTROGENS; PLANT EXTRACTS; PLANT PREPARATIONS; RALOXIFENE; RATS; RATS, WISTAR; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SOYBEANS; UTERUS;

EID: 0041424883     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00252-8     Document Type: Article

References (39)

1. Lindsay R., Gallagher J.C., Kleerekoper M., Pickar J.H. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. J. Am. Med. Assoc. 287:2002;2668-2676.
2. Speroff L., Rowan J., Symons J., Genant H., Wilborn W. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. J. Am. Med. Assoc. 276:1996;1397-1403.
3. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139:1998;4252-4263.
4. Enmark E., Gustafsson J.A. Oestrogen receptors - an overview. J. Int. Med. 246:1999;133-138.
5. Eng F.C., Barsalou A., Akutsu N., Mercier N., Zechel C., Mader S., White J.H. Differential classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain. J. Biol. Chem. 273:1998;28371-28377.
6. Smith C.L., Nawaz Z., O'Malley B.W. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen 4-hydroxy tamoxifen. Mol. Endocrinol. 11:1997;657-666.
7. Philips D.M., Balducci L. Current management of breast cancer. Am. Fam. Physician. 53:1996;657-665.
8. Muchmore D.B. Raloxifene: a selective estrogen receptor modulator (SERM) with multiple target system effects. Oncologist. 5:2000;388-392.
9. Barrett-Connor E., Grady D., Sashegyi A., Anderson P.W. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: 4-year results from the MORE (multiple outcomes of raloxifene evaluation) randomized trial. J. Am. Med. Assoc. 287:2002;847-857.
10. Kearney C.E., Purdie D.W. Selective estrogen receptor modulators. Climacteric. 1:1998;143-147.
11. Gajdos C., Jordan V.C. Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade. Clin. Breast Cancer. 2:2002;272-281.
12. Tham D.M., Gardner C.D., Haskell W.L. Potential health benefits of dietary phyto-estrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83:1998;2223-2235.
13. Setchell K.D.R. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 68(Suppl):1998;1333S-1346S.
14. Breuer B., Wallenstein S., Anderson R. Effects of tamoxifen on bone fractures in older nursing home residents. J. Am. Geriatr. Soc. 46:1998;968-972.
15. McDonnell D.P., Connor C.E., Wijayaratne A., Chang C.Y., Norris J.D. Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog. Horm. Res. 57:2002;295-316.
16. Silfen S.L., Ciaccia A.V., Bryant H.U. Selective estrogen receptor modulators: tissue selectivity and differential uterine effects. Climateric. 2:1999;268-283.
17. Somjen D., Waisman A., Kaye A.M. Tissue selective action of tamoxifen methiodide, raloxifene and tamoxifen on creatine kinase B activity in vitro and in vivo. J. Steroid Biochem. Mol. Biol. 59:1996;389-396.
18. Potter S.M., Baum J.A., Teng H., Stillman R.J., Shay N.F., Erdman J.W. Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 68(Suppl):1998;1375S-1379S.
19. Ewies A.A. Phytoestrogens in the management of the menopause: up-to-date. Obstet. Gynecol. Surv. 57:2002;306-313.
20. Malnick S.D., Shaer A., Soreq H., Kaye A.M. Estrogen-induced creatine kinase in the reproductive system of the immature female rat. Endocrinology. 113:1983;1907-1909.
21. Somjen D., Weisman Y., Harell A., Berger E., Kaye A.M. Direct and sex-specific stimulation by sex steroids of creatine kinase activity and DNA synthesis in rat bone. Proc. Natl. Acad. Sci. U.S.A. 86:1989;3361-3365.
22. Somjen D., Waissman A., Weisman Y., Kaye A.M. Nonhypercalcemic analogs of vitamin D stimulate creatine kinase B activity in osteoblast-like ROS 17/2.8 cells and up-regulate their responsiveness to estrogens. Steroids. 63:1998;340-343.
23. Tamir S., Eizenberg M., Somjen D., Izrael S., Vaya J. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J. Steroid Biochem. Mol. Biol. 78:2001;291-296.
24. Wang H.J., Murphy P.A. Mass balance study of isoflavones during soybean processing. J. Agric. Food Chem. 44:1996;2377-2383.
25. Yoles I., Kaplan B., Seidman D.S., Chayen B. Phytoestrogens: a time-tested solution for menopausal symptoms revisited. Obstet. Gynecol. 99(Suppl):2002;58S.
26. Turner R.T., van der Steenhover J.J., Bell N.H. The effect of ovariectomy and 17b-estradiol on bone histomorphometry in growing rats. J. Bone Mineral. Res. 2:1987;115-122.
27. Somjen D., Mor Z., Kaye A.M. Age dependence and modulation by gonadectomy of the sex-specific response of rat diaphyseal bone to gonadal steroids. Endocrinology. 134:1994;809-814.
28. Tamir S., Eizenberg M., Somjen D., Izrael S., Vaya J. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res. 60:2000;5704-5709.
29. J. Vaya, S. Tamir, D. Somjen, Estrogen-like activity of licorice root extract and its constituent (in preparation).
30. Liggins J., Grimwood R., Bingham S.A. Extraction and quantification of lignan phytoestrogens in food and human samples. Anal. Biochem. 287:2000;102-109.
31. Wiseman H. The therapeutic potential of phytoestrogens. Exp. Opin. Investig. Drugs. 9:2000;1829-1840.
32. Lee H.P., Gouerly l., Duffy S.W., Esteve J., Lee J., Day N.E. Dietary effects on breast-cancer risk in Singapore. Lancet. 337:1991;1197-1200.
33. Fournier B.F., Erdman J.W. Jr., Gordon G.B. Soy, its components and cancer prevention: a review of the in vitro, animal and human data. Cancer Epidemiol. Biomarkers Prev. 7:1998;1055-1065.
34. Valente M., Buflino L., Castiglione G.N., D'Angelo R., Mancuso A., Galoppi P., Zichella X. Effects of 1-year treatment with isoipriflavone on bone in post-menopausal women with low bone mass. Calcif. Tissue Int. 54:1994;377-380.
35. Markiewicz L., Garey J., Adlerkreutz H., Gurpide E. In vitro bioassays of nonsteroidal phytoestrogens. J. Steroid Biochem. Mol. Biol. 45:1993;399-405.
36. Barnes S., Boersma B., Patel R., Kirk M., Darley-Usmar V.M., Kim H., Xu J. Isoflavonoids and chronic disease: mechanisms of action. Biofactors. 12:2000;209-215.
37. Kaye A.M., Kim T.-Y., Kohen F., Somjen D. Anabolic effects of estrogen and parathyroid hormone on skeletal tissues: the use of creatine kinase B activity as a response marker. Arch. Gerontol. Geriatr. 24:1997;197-209.
38. Kim T.-Y., Vargas V., Mayer H., Somjen D., Kaye A.M. Selective anabolic effects of muteins of mid-region PTH fragments on skeletal tissues of prepubertal rats. Bone. 30:2002;78-84.
39. Kaye A.M., Spatz M., Waisman A., Sasson S., Tamir S., Vaya J., Somjen D. Paradoxical interactions among estrogen receptors. J. Steroid Biochem. Mol. Biol. 76:2001;85-93.